U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07105371) titled 'Patients With ALS and Other Motor Discorders Will be Treated With Mesenchymal Cell Exosome Solution' on July 22.
Brief Summary: Patients with ALS and other Motor Discorders will be treated with mesenchymal cell exosome solution.
Study Start Date: July 14, 2024
Study Type: INTERVENTIONAL
Condition:
Motor Disorders
Intervention:
BIOLOGICAL: AlloEx exosomes
This is an intranasal treatment of exosomes derived from mesenchymal stem cells.
Recruitment Status: COMPLETED
Sponsor: The Foundation for Orthopaedics and Regenerative Medicine
Disclaimer: Curated by HT Syndication....